Major Singapore deal sets out route for global expansion

24 July 2023
/ News

We at Emblation have partnered with one of the top aesthetic equipment distributors in Singapore to expand the global reach of our innovative microwave device.

Emblation launches major $2m US clinical trial

15 June 2023
/ News

The Emblation team is undertaking a rigorous clinical trial which could transform the fortunes of our microwave treatments in the US.

Swift® could hold key to cervical cancer treatment

7 May 2023
/ News

Technology pioneered by our Emblation team has featured in promising new research which could deliver less painful and more effective treatment for cervical cancer patients.

Celebrating 200,000 treatments

21 September 2022
/ News

Emblation has reached a milestone after completing 200,000 treatments with our innovative microwave device for treating common skin problems.

Health tech innovator sitting pretty with move into skin clinic

9 August 2022
/ News

Our exciting skin treatment device has made its first crossover breakthrough into an aesthetic clinic, after taking the podiatry world by storm.

IDE Approval Received from the FDA for the SWIFT multi-centre, open, randomized, controlled, parallel-group, blind-assessed trial

6 June 2022
/ News

IDE approval was received in April 2022 from the FDA for the SWIFT multi-centre, open, randomized, controlled, parallel-group, blind-assessed trial.

Scottish health tech innovator hits 100,000 treatments in UK

31 May 2022
/ News

The Emblation team are proud to have launched in Europe’s biggest healthcare market, after striking a partnership deal with a leading German medical device company.